BiomX Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dover, DE
SEC filing record 1 source field available
Fiscal year end
31 December
BiomX Inc. has filed 553 SEC EDGAR filings since 04 May 2018

SEC filing history

Showing 51-75 of 553 matching filings.

Per page
25
Current page
3
8-K File 001-38762

CURRENT REPORT

Filing date
13 Feb 2026
Reporting date
09 Feb 2026
Next action
Verify source filing
DEF 14A File 001-38762

DEFINITIVE PROXY STATEMENT

Filing date
13 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-293308

UPLOAD filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-90744

SCHEDULE 13D/A filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
10 Feb 2026
Reporting date
04 Feb 2026
Next action
Verify source filing
S-3 File 333-293308

REGISTRATION STATEMENT

Filing date
09 Feb 2026
Reporting date
Not listed
Next action
Verify source filing
PRE 14A File 001-38762

PRELIMINARY PROXY STATEMENT

Filing date
03 Feb 2026
Reporting date
03 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90744

SCHEDULE 13G/A filing

Filing date
29 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-90744

SCHEDULE 13D filing

Filing date
26 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-570448

D filing

Filing date
20 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 Jan 2026
Reporting date
13 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
07 Jan 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
29 Dec 2025
Reporting date
26 Dec 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
11 Dec 2025
Reporting date
11 Dec 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
08 Dec 2025
Reporting date
08 Dec 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
25 Nov 2025
Reporting date
25 Nov 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
17 Nov 2025
Reporting date
17 Nov 2025
Next action
Verify source filing
10-Q File 001-38762

QUARTERLY REPORT

Filing date
12 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
12 Nov 2025
Reporting date
12 Nov 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
17 Oct 2025
Reporting date
17 Oct 2025
Next action
Verify source filing
8-K File 001-38762

CURRENT REPORT

Filing date
17 Oct 2025
Reporting date
17 Oct 2025
Next action
Verify source filing
ARS File 001-38762

FORM ARS

Filing date
28 Aug 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38762

DEFINITIVE ADDITIONAL MATERIALS

Filing date
28 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .